RBP4 and metabolic dysfunction-associated steatotic liver disease: These findings elucidate the dual regulatory role of Rbp4 in orchestrating the inflammatory microenvironment and metabolic reprogramming, highlighting its pathogenic contribution to non-alcoholic fatty liver disease (NAFLD) progression.